Workflow
Absci(ABSI) - 2024 Q4 - Earnings Call Transcript
ABSIAbsci(ABSI)2025-03-19 04:30

Absci (ABSI) Q4 2024 Earnings Call March 18, 2025 04:30 PM ET Company Participants Alexander Khan - VP of Finance & Head of Investor RelationsSean McClain - Founder, CEO & DirectorZach Jonasson - Chief Financial Officer & Chief Business OfficerChristian Stegmann - Senior Vice President of Drug CreationArseniy Shabashvili - Vice PresidentJacqueline Kisa - Equity Research AssociateDebanjana Chatterjee - Director Conference Call Participants None - AnalystVikram Purohit - AnalystGil Blum - Senior AnalystRamaka ...